Wall Street Analysts Believe Sage Therapeutics (SAGE) Could Rally 42.02%: Here's is How to Trade

Sage Therapeutics, Inc. (SAGE) closed the last trading session at $6.14, gaining 9.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.72 indicates a 42% upside potential.The average comprises 18 short-term price targets ranging from a low of $4 to a high of $17, with a standard deviation of $3.54. While the lowest estimate indicates a decline of 34.9% from the current price leve ...